Volume 129, Issue 5-6

Search all Journal of Neural Transmission articles

June 2022

Special Issue: Neurobiology of Neuropsychiatric Disorders: A Tribute to Peter Riederer

Issue Editors:

Etienne C. Hirsch,
Toshiharu Nagatsu,
Heinz Reichmann,
Jürgen Deckert,
Moussa B. H. Youdim

34 articles in this issue

Special issue in honor of Peter Riederer at the occasion of his 80th birthday
Etienne C. Hirsch
Editorial 16 May 2022 Pages: 441 - 441
Peter Riederer, a translational neurobiochemist
Toshiharu Nagatsu
Heinz Reichmann
Editorial 07 April 2022 Pages: 443 - 444
Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson’s disease
Richard M. Kostrzewa
Neurology and Preclinical Neurological Studies - Review Article 12 March 2022 Pages: 445 - 461
RNF166 plays a dual role for Lys63-linked ubiquitination and sumoylation of its target proteins
Ih-Yeon Hwang
Chang-Ki Oh
Young J. Oh
Neurology and Preclinical Neurological Studies - Original Article 27 November 2021 Pages: 463 - 475
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
Gloria S. Benson
Chris Bauer
Lutz Frölich
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 21 January 2022 Pages: 477 - 486
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview
Wolf-Dieter Rausch
Feixue Wang
Khaled Radad
Neurology and Preclinical Neurological Studies - Review Article Open access 23 April 2022 Pages: 487 - 495
Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson’s disease
Björn Falkenburger
Theodoros Kalliakoudas
Heinz Reichmann
Neurology and Preclinical Neurological Studies - Review Article Open access 10 May 2022 Pages: 497 - 503
A brief history of brain iron accumulation in Parkinson disease and related disorders
Paul B. Foley
Dominic J. Hare
Kay L. Double
Neurology and Preclinical Neurological Studies - Review Article Open access 09 May 2022 Pages: 505 - 520
Pallidal degenerations and related disorders: an update
Kurt A. Jellinger
Neurology and Preclinical Neurological Studies - Review Article 07 August 2021 Pages: 521 - 543
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
Eva Gschmack
Camelia-Maria Monoranu
Carsten Scheller
Neurology and Preclinical Neurological Studies - Original Article Open access 01 April 2022 Pages: 545 - 555
Wilful pathogens provoke a gut feeling in Parkinson’s disease
Jeswinder Sian-Hülsmann
Neurology and Preclinical Neurological Studies - Review Article 19 December 2021 Pages: 557 - 562
Cognition, motor symptoms, and glycolipid metabolism in Parkinson’s disease with depressive symptoms
Cong Yao
Lichao Niu
Jie Li
Neurology and Preclinical Neurological Studies - Original Article 27 November 2021 Pages: 563 - 573
The reduction of hippocampal volume in Parkinson’s disease
Pavel Říha
Luboš Brabenec
Irena Rektorová
Neurology and Preclinical Neurological Studies - Original Article 05 February 2022 Pages: 575 - 580
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders
Thomas Brücke
Christof Brücke
Neurology and Preclinical Neurological Studies - Review Article 15 December 2021 Pages: 581 - 594
Complex motion series performance differs between previously untreated patients with Parkinson’s disease and controls
Thomas Müller
Wilfried Kuhn
Neurology and Preclinical Neurological Studies - Original Article 12 November 2021 Pages: 595 - 600
Parkinson and depression: review and outlook
Gerd Laux
Psychiatry and Preclinical Psychiatric Studies - Review Article 04 January 2022 Pages: 601 - 608
Psychiatry: Peter Falkai
Peter Falkai
Editorial Open access 07 April 2022 Pages: 609 - 610
Failed regeneration and inflammation in schizophrenia: two sides of the same coin?
Peter Falkai
Andrea Schmitt
Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 22 April 2022 Pages: 611 - 615
Superoxide dismutase isozymes in cerebral organoids from autism spectrum disorder patients
Morten Ejlersen
Mirolyuba Ilieva
Tanja Maria Michel
Psychiatry and Preclinical Psychiatric Studies - Original Article 09 March 2022 Pages: 617 - 626
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer
Masaru Tanaka
Eleonóra Spekker
László Vécsei
Psychiatry and Preclinical Psychiatric Studies - Review Article 28 May 2022 Pages: 627 - 642
The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin
Gavin P. Reynolds
Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 21 December 2021 Pages: 643 - 647
Investigating mechanisms of cognitive control training: neural signatures of PASAT performance in depressed patients
Anja Sommer
Andreas J. Fallgatter
Christian Plewnia
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 23 November 2021 Pages: 649 - 659
Association of polygenic risk scores, traumatic life events and coping strategies with war-related PTSD diagnosis and symptom severity in the South Eastern Europe (SEE)-PTSD cohort
Heike Weber
Adam X. Maihofer
Angelika Erhardt
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 27 November 2021 Pages: 661 - 674
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1 year of COVID-19
Anna Maria Werling
Susanne Walitza
Renate Drechsler
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 02 June 2022 Pages: 675 - 688
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
R. Taurines
S. Fekete
K. M. Egberts
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 18 March 2022 Pages: 689 - 701
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage
F. Bavato
S. Stamatakos
B. B. Quednow
Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 14 April 2022 Pages: 703 - 711
Treatment; Moussa B.H. Youdim
Moussa B. H. Youdim
Editorial 08 April 2022 Pages: 713 - 714
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer’s disease therapy
Moussa B. H. Youdim
Neurology and Preclinical Neurological Studies - Original Paper 21 February 2022 Pages: 715 - 721
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease
Wolfgang H. Jost
Neurology and Preclinical Neurological Studies - Review Article Open access 02 February 2022 Pages: 723 - 736
Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors
Makoto Naoi
Wakako Maruyama
Masayo Shamoto-Nagai
Neurology and Preclinical Neurological Studies - Review Article 15 October 2021 Pages: 737 - 753
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease
Xian Zhou
Madhuri Venigalla
Gerald Münch
Neurology and Preclinical Neurological Studies - Review Article 16 March 2022 Pages: 755 - 771
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease
Iva Markulin
Marija Matasin
Melita Salković-Petrisic
Neurology and Preclinical Neurological Studies - Review Article 04 January 2022 Pages: 773 - 804
Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies
Johannes M. Dijkstra
Toshiharu Nagatsu
Neurology and Preclinical Neurological Studies - Review Article 10 December 2021 Pages: 805 - 828
Botulinum toxin therapy: past, present and future developments
Dirk Dressler
Eric A. Johnson
Neurology and Preclinical Neurological Studies - Review Article Open access 09 April 2022 Pages: 829 - 833

Volume 129, Issue 5-6

Search

Navigation